The Multidisciplinary Approach to Treating Prostate Cancer Using Radiopharmaceuticals
The Androgen Axis Is Not the Only Driver of Advanced Prostate Cancer Disease Progression
E. David Crawford, MD
University of Colorado, Denver
Aurora, CO
Radiopharmaceuticals: Has There Been Progress?
Neal D. Shore, MD, FACS
Atlantic Urology Clinics, LLC
Myrtle Beach, SC
Osseous Metastatic Disease and Radium 223: Lessons Learned and Future Directions
Phillip J. Koo, MD
Banner MD Anderson Cancer Center
Gilbert, AZ
Daniel P. Petrylak, MD
Yale Cancer Center
New Haven, CT